Health ❯ Healthcare ❯ Clinical Trials ❯ Phase 3 Trials

Drug Efficacy

Merck’s Oral PCSK9 Pill Matches Injectables in Phase 3, Setting Up 2026 FDA Bid

Merck plans to seek FDA review in early 2026 based on these Phase 3 lipid-lowering results.

Lilly’s Orforglipron Pill Hits Phase 3 Goals, Clearing Path to Global Filings